Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
about
Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox.Cost-effectiveness of vaccination against herpes zoster.Active learning to understand infectious disease models and improve policy making.Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.Cytomegalovirus seropositivity is associated with herpes zoster.Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.The 'Dynamic' Marriage Between Varicella and ZosterVaricella paediatric hospitalisations in Belgium: a 1-year national surveyInfluence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.Post-herpetic neuralgia - a review of current management and future directions.The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study
P2860
Q33683179-ABF44377-883B-41C8-805D-C07C77695086Q34291150-0E278237-DB80-4D74-A9D7-356156A2459CQ35151816-03343ED7-6834-4353-818E-1EFC1480C10FQ35652212-2238EBE6-BF7B-44D7-8A65-7246B232CF2CQ35887759-8872989F-9DC4-4008-8B39-0496F313A7B8Q36252698-40877A6D-2054-4B4F-B05F-694CC846C70DQ36253248-111D25BA-E02E-40D1-9E3E-70048651C49AQ36475701-44B65CF8-A6FC-47A3-B104-DCE9211EBFF2Q37643309-61E5E973-1823-4C45-8697-64A769C25BFCQ40640266-3C0EB811-2D46-4B18-85DB-A3211ABBE422Q42273664-DD49E266-145B-4459-B32D-0C82028B73C3Q47242634-8565AB18-9013-485D-9FE3-36FF8C818AB7Q57395637-F00EF6C0-9C6E-411E-BF63-095436FE0757
P2860
Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Childhood varicella-zoster vir ...... or without exogenous boosting?
@en
Childhood varicella-zoster vir ...... or without exogenous boosting?
@nl
type
label
Childhood varicella-zoster vir ...... or without exogenous boosting?
@en
Childhood varicella-zoster vir ...... or without exogenous boosting?
@nl
prefLabel
Childhood varicella-zoster vir ...... or without exogenous boosting?
@en
Childhood varicella-zoster vir ...... or without exogenous boosting?
@nl
P2093
P2860
P356
P1476
Childhood varicella-zoster vir ...... or without exogenous boosting?
@en
P2093
Albert Jan van Hoek
Joke Bilcke
Philippe Beutels
P2860
P304
P356
10.4161/HV.23334
P577
2013-01-15T00:00:00Z